Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0
From AccurKardia
Via Business Wire
News headline image
Vizgen Announces $48 Million Financing
From Vizgen, Inc.
Via Business Wire
News headline image
Coincheck Group Signs Agreement to Acquire 3iQ, a Global Pioneer in Digital Asset Investment Solutions
From Coincheck Group N.V.
Via Business Wire
Tickers CNCK
News headline image
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Tickers XERS
News headline image
Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development
From Tubulis
Via Business Wire
News headline image
Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases
From Candid Therapeutics, Inc.
Via Business Wire
News headline image
Enhanced Digital Group Announces Series A Financing
From Enhanced Digital Group Inc.
Via Business Wire
News headline image
Echo Water Unveils the Echo One: An Ultra-Pure Hydrogen Water System
From Echo Water
Via Business Wire
News headline image
NIQ and Kodiak Announce Retail Measurement Agreement to Drive Breakfast Category Growth
From NIQ Global Intelligence plc
Via Business Wire
Tickers NIQ
News headline image
TransactionTree Appoints Kevin Saum as Chief Executive Officer to Lead Next Phase of Growth
From TransactionTree
Via Business Wire
News headline image
VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS
From VectorY Therapeutics
Via Business Wire
News headline image
PlusAI on Track to Launch Factory-Built Commercial Autonomous Trucks Next Year
From PlusAI
Via Business Wire
Tickers CCIX
News headline image
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets
From Bruker Corporation
Via Business Wire
Tickers BRKR
News headline image
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
From Canopy Growth Corporation
Via Business Wire
Tickers CGC TSX:WEED
News headline image
Tanger Announces Pricing of Upsized Exchangeable Senior Notes Offering
From Tanger
Via Business Wire
Tickers SKT
News headline image
Bidgely Redefines Energy AI in 2025: From Machine Learning to Agentic AI
From Bidgely
Via Business Wire
News headline image
Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pipeline and Helicon Platform
From Parabilis Medicines
Via Business Wire
News headline image
Neogen Announces Second-Quarter 2026 Results
From Neogen Corporation
Via Business Wire
Tickers NEOG
News headline image
Protege Raises $30 Million Led by a16z to Unlock Access to Data for AI Development
From Protege
Via Business Wire
News headline image
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
From Amylyx Pharmaceuticals, Inc.
Via Business Wire
Tickers AMLX
News headline image
Osel Enters Agreement with SWOG Cancer Research Network for First-Ever Pivotal Trial of a Microbiome-Based Therapy in Oncology
From Osel Inc.
Via Business Wire
News headline image
K1x and Juno Announce Strategic Partnership to Provide Industry-Leading Tax Automation
From K1x Inc.
Via Business Wire
News headline image
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Tickers ENTA
News headline image
Virometix AG Announces Positive Data from Phase 1 Trial of V-212, a Fully Synthetic, Serotype-Independent Vaccine Development Candidate for the Prevention of Pneumococcal Disease
From Virometix AG
Via Business Wire
News headline image
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
From SpliceBio
Via Business Wire
News headline image
Concord Appoints Chris Baker as Executive Chairman
From Concord
Via Business Wire
News headline image
TD SYNNEX Reports Record Fiscal 2025 Fourth Quarter Results
From TD SYNNEX
Via Business Wire
Tickers SNX
News headline image
U.S. Army Selects Striveworks for AI Test and Evaluation
From Striveworks
Via Business Wire
News headline image
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
From AstraZeneca
Via Business Wire
Tickers AZN
News headline image
First Foundation Inc. Announces Fourth Quarter 2025 Earnings Release Details
From First Foundation Inc.
Via Business Wire
Tickers FFWM
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.